These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25807276)

  • 21. PharmGKB: understanding the effects of individual genetic variants.
    Sangkuhl K; Berlin DS; Altman RB; Klein TE
    Drug Metab Rev; 2008; 40(4):539-51. PubMed ID: 18949600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations: implications for clinical implementation of pharmacogenomics.
    Chan SL; Samaranayake N; Ross CJ; Toh MT; Carleton B; Hayden MR; Teo YY; Dissanayake VH; Brunham LR
    Pharmacogenet Genomics; 2016 Jan; 26(1):28-39. PubMed ID: 26444257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphisms of pharmacogenomic VIP variants in the Hui population from Ningxia Province of China.
    Zhou W; Guo J; Li Y; Ma X; Yang S; Wei J; Zhang H; Zhang S; Jin T
    Funct Integr Genomics; 2023 Mar; 23(2):85. PubMed ID: 36930384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphisms of pharmacogenomic VIP variants in the Lahu population from Yunnan Province.
    Dou X; Yang S; Zhang W; Meng W; Zhao W; Hao J; Hu X; Guo L; Jin T
    Gene; 2022 Nov; 844():146825. PubMed ID: 35995116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PACdb: a database for cell-based pharmacogenomics.
    Gamazon ER; Duan S; Zhang W; Huang RS; Kistner EO; Dolan ME; Cox NJ
    Pharmacogenet Genomics; 2010 Apr; 20(4):269-73. PubMed ID: 20216476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PharmGKB: an integrated resource of pharmacogenomic data and knowledge.
    Gong L; Owen RP; Gor W; Altman RB; Klein TE
    Curr Protoc Bioinformatics; 2008 Sep; Chapter 14():14.7.1-14.7.17. PubMed ID: 18819074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge.
    Hernandez-Boussard T; Whirl-Carrillo M; Hebert JM; Gong L; Owen R; Gong M; Gor W; Liu F; Truong C; Whaley R; Woon M; Zhou T; Altman RB; Klein TE
    Nucleic Acids Res; 2008 Jan; 36(Database issue):D913-8. PubMed ID: 18032438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphisms analysis of pharmacogenomic VIP variants in Bai ethnic group from China.
    Chen W; Ding H; Cheng Y; Li Q; Dai R; Yang X; Zhang C
    Mol Genet Genomic Med; 2019 Sep; 7(9):e884. PubMed ID: 31361092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human loci involved in drug biotransformation: worldwide genetic variation, population structure, and pharmacogenetic implications.
    Maisano Delser P; Fuselli S
    Hum Genet; 2013 May; 132(5):563-77. PubMed ID: 23354977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SNP@Evolution: a hierarchical database of positive selection on the human genome.
    Cheng F; Chen W; Richards E; Deng L; Zeng C
    BMC Evol Biol; 2009 Sep; 9():221. PubMed ID: 19732458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphisms of pharmacogenomic VIP variants in Li nationality of southern China.
    Ding Y; He P; He N; Li Q; Sun J; Yao J; Yi S; Xu H; Wu D; Wang X; Jin T
    Environ Toxicol Pharmacol; 2016 Mar; 42():237-42. PubMed ID: 26901752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PharmGKB, an Integrated Resource of Pharmacogenomic Knowledge.
    Gong L; Whirl-Carrillo M; Klein TE
    Curr Protoc; 2021 Aug; 1(8):e226. PubMed ID: 34387941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BioBin: a bioinformatics tool for automating the binning of rare variants using publicly available biological knowledge.
    Moore CB; Wallace JR; Frase AT; Pendergrass SA; Ritchie MD
    BMC Med Genomics; 2013; 6 Suppl 2(Suppl 2):S6. PubMed ID: 23819467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Singapore Pharmacogenomics Portal: a web resource for evaluating human genetic variations of genes responsible for drug responses.
    Wong LP; Poh WT; Chan SL; Tan LL; Toh DS; Chia KS; Sung C; Teo YY
    Pharmacogenet Genomics; 2013 Jun; 23(6):329-32. PubMed ID: 23546522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using PharmGKB to train text mining approaches for identifying potential gene targets for pharmacogenomic studies.
    Pakhomov S; McInnes BT; Lamba J; Liu Y; Melton GB; Ghodke Y; Bhise N; Lamba V; Birnbaum AK
    J Biomed Inform; 2012 Oct; 45(5):862-9. PubMed ID: 22564551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome wide signatures of positive selection: the comparison of independent samples and the identification of regions associated to traits.
    Barendse W; Harrison BE; Bunch RJ; Thomas MB; Turner LB
    BMC Genomics; 2009 Apr; 10():178. PubMed ID: 19393047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource.
    McDonagh EM; Whirl-Carrillo M; Garten Y; Altman RB; Klein TE
    Biomark Med; 2011 Dec; 5(6):795-806. PubMed ID: 22103613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variation of pharmacogenomic VIP variants in the Chinese Li population: an updated research.
    Yang S; Dou X; Wang Z; Zhang W; Ding K; Meng W; Li H; Liu J; Liu Y; Jin T
    Mol Genet Genomics; 2022 Mar; 297(2):407-417. PubMed ID: 35146537
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.